Treatment-Resistant Epilepsy
Israeli Drug-Resistant Epilepsy Study — CBD-Enriched Sub-Lingual Oil
Research overview
An Israeli study of drug-resistant epilepsy evaluating a CBD-enriched sub-lingual oil formulation, complementing the company’s broader pediatric epilepsy research program.
Detailed study parameters — participant numbers, dates, participating institutions, and quantitative results — are pending verification and appear as placeholders until a verified source is available. No figures are invented.
Outcomes
Quantitative outcomes will be published here once approved for publication with a verified source.
Safety observations
Safety observations will be summarized once a verified source is available.
Study limitations
- Study parameters and results are pending verification and are shown as placeholders.
- This page is for scientific and corporate information only and is not a treatment recommendation.